All attending UK organisations

UK companies attending Bio-Europe Spring 2018 as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK, National Institute for Health Research: UK stand, booth #60

UK stand (booth 60) and Regional Groups:
Arcinova, BioPartner UK, Clinical Network Services (UK), Colibri Scientific, CPRD, Karma Oncology, Masters Speciality Pharma, National Institute for Health Research, Scottish Development International, Selcia, United Life Sciences

Other UK companies associated with the delegation*:
Abzena, Aptus Clinical, Aspire Pharma, BioAscent, Bioven, Cancer Research UK, Cello Health Consulting, CIMYM BioSciences, Circassia Pharmaceuticals, Clinical Accelerator, Colliers International Property, CPRD, Crystec, Diamond BioPharm, e Therapeutics , ERA Consulting UK, Exvastat, Fusion Antibodies, Haoma Medica, HC Pharma Consulting UK, HungaroTrial, IAG, IDACO, Ipsen, Ipsen Biopharm, J A Kemp, KOI CONSULTING PARTNERS, Liftstream, Medherant, Mironid, N4 Pharma, Oncolytika, Oppilotech, PharmaVentures, Phastar, Pneumagen, Quay Pharmaceuticals, Summit Therapeutics, Sygnature Discovery, SYNthesis med chem, Therakind, Torreya, Transcrip, VirionHealth.

UK Presenting companies:
Avillion LLP, Fujifilm Diosynth, Mundipharma International, Nanogenic Solutions, Nerre Therapeutics, NetScientific, Oisin Biotechnologies, Rexgenero, Synpromics

All attending UK companies:
3M UNITED KINGDOM, Abcam, Abingworth, Abzena, ACCORD HEALTHCARE, Addison Whitney, Akari Therapeutics, Alacrita Consulting, Alliance Pharma, Almac Discovery, Alpha Blue Ocean, ALSA Holdings, Apex Healthcare Consulting, APTUS CLINICAL, Arcinova, Arix Bioscience, Aspire Pharma, AstraZeneca, Asymchem, Athena Market Access Solutions, Avillion LLP, Barrington James, BenevolentAI, BioAscent, Bionow, BioPartner UK, BioPharm Insight, Bio-Rad Laboratories, Bioven, Blueberry Therapeutics, Cancer Research UK, Catalyst Advisors, CatSci, Celerion, Cell Medica, Cello Health Consulting, CEPI, Charles River, Chiltern, Chugai Pharma Europe, CIMYM BioSciences, Circassia Pharmaceuticals, Citigate Dewe Rogerson, Clinical Accelerator, Clinical Network Services (UK), CN Bio Innovations, Cobra Biologics, Colibri Scientific, Colliers International, COLONIS PHARMACEUTICALS, Consilient Health, Coulter Partners, Covance Inc, CPRD, CRA, Crescendo Biologics, Crystec, Cumulus Oncology, Decision Resources Group, Destiny Pharma, Diamond Pharma Services, Dyadic International Inc, e Therapeutics, EBD Academy, Edison, Elasmogen, EP Vantage, ERA Consulting UK, Ergomed, Ethypharm, EUSA Pharma, Evaluate, Evernow Publishing, Exvastat, F-star Biotechnology, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, GalbraithWight, GlobalData, Haoma Medica, HC Pharma Consultancy, Heptares Therapeutics, Hikma Pharmaceuticals, HungaroTrial, IAG, IDACO Consulting, ImmunoBiology, Immunocore, ImmuPharma, InClinica, Innovation Forum Manchester, Intract Pharma, Iontas, Ipsen Biopharm, J A Kemp, JJDC, Johnson & Johnson Innovation, Karma Oncology, KNect365 LifeSciences, KOI CONSULTING PARTNERS, Kyowa Kirin, Latham & Watkins, Liftstream, Lonza, MAC Clinical Research, Manchester Science Partnerships: Alderley Park, Marlin Bioconsulting, Masters Speciality Pharma, Mawdsleys Pharma, Medherant, MedImmune, MediWales, MedPharm, Mereo BioPharma Group, Mironid, Mitsubishi Tanabe Pharma, MSD, Mundipharma International, MVM Partners LLP, N4 Pharma, Nanogenic Solutions, National Institute for Health Research, National Phenotypic Screening Centre - NPSC, Nature Biotechnology, Nature Research, NERRE THERAPEUTICS, NetScientific, NM Rothschild & Sons, NodThera, NORGINE, Norgine Ventures, Novella Clinical, Novintum Bioscience Limited, OBN (UK), Oncolytika, One Nucleus, Ono Pharma UK, Oppilotech, Orbit Discovery, Oval Medical Technologies, Oxford Biotherapeutics, PAREXEL, Parkinson's UK, Pharma Intelligence - Informa, Pharmacircle, PharmaConsulting, Pharmalicensing, PharmaVentures, Phastar, Pneumagen, Precision for Oncology, ProAxsis, ProClinical, PsiOxus Therapeutics, Purolite, Quay Pharmaceuticals, Queen Mary University, Queens University Belfast, Quotient Sciences, RDI Drug News, Rephine, Reverse Rett, Rexgenero, Richmond Pharmacology, Rosemont Pharmaceuticals (Perrigo ), RoslinCT, Sage Group, Samedan, Scottish Development International, Scrip & The Pink Sheet, Sekisui, Selcia, SGS Vitrology, Sharp clinical services, Shield Therapeutics, Silence Therapeutics, Silicon Valley Bank, SMARTANALYST, Spybiotech, SQN Clinical, Stelis Biopharma, Stratophase, suAzio Consulting, Summit Therapeutics, Sygnature Discovery, Symbiosis Pharmaceutical Services, Synpromics, SYNthesis med chem, Teijin Pharma, TFS International, The Economist, The Fulford Group, The Institute of Cancer Research, The University of Edinburgh, Theradex Europe, Therakind, Theramex HQ UK, Tolley Health Economics, Torreya, Transcrip, Tusk Therapeutics, UK Bioindustry Association, UK Department for International Trade, United Life Sciences, University of Bristol, University of Dundee Drug Discovery Unit, University of Glasgow, University of Strathclyde, ValiSeek, VCLS, Veristat, Vernalis, Viramal, VirdisGroup, VirionHealth, Wellcome Trust, Wildwood Ventures, Wilmington.
(217)

* Save money and join them here!